Xeploceff-O Tablet is a combination antibiotic formulation containing Cefixime 200mg and Ofloxacin 200mg, indicated for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Ofloxacin, a fluoroquinolone antibiotic, acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription, thereby preventing bacterial proliferation. The synergistic effect of these two agents makes Xeploceff-O effective against various Gram-positive and Gram-negative pathogens, including respiratory tract infections, urinary tract infections, gastrointestinal infections, and skin and soft tissue infections. It is particularly useful in cases where mixed infections or resistant strains are suspected. The tablet should be administered as prescribed by a healthcare professional, typically once or twice daily, depending on the severity and type of infection. Patients should complete the full course of therapy to prevent the development of resistance. Caution is advised in patients with known hypersensitivity to cephalosporins or fluoroquinolones, and it is contraindicated in individuals with a history of tendon disorders related to fluoroquinolone use. Common side effects may include gastrointestinal disturbances, dizziness, and hypersensitivity reactions. Monitoring is recommended during prolonged therapy.